Gopi S. Mohan, M.D., Ph.D.
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Emory University School of Medicine, Atlanta, GA, USA, MD, Medicine |
| 2013 | Emory University Laney Graduate School, Atlanta, GA, USA, PhD, Immunology and Molecular Pathogenesis |
| 2004 | Amherst College, Amherst, MA, USA, BA, Chemistry, Music |
Postgraduate Training
| 2020-2022 | Clinical Fellowship, Cellular Therapies, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA |
| 2018-2020 | Clinical Fellowship, Pediatric Critical Care Medicine, Massachusetts General Hospital, Boston, MA |
| 2016-2018 | Clinical Residency, Pediatrics, Boston Children's Hospital/Boston Combined Residency Program, Boston, MA |
| 2015-2016 | Clinical Internship, Pediatrics, Boston Children's Hospital/Boston Combined Residency Program, Boston, MA |
Board Certifications
| 2020 | American Board of Pediatrics (General Pediatrics) |
| 2020 | American Board of Pediatrics (Critical Care) |
Selected Publications
Peer-Reviewed Articles
- Baumeister SHC, Mohan GS, Elhaddad A, Lehmann L. Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation. Front Oncol 12:841117, 2022. e-Pub 2022. PMID: 35402259.
- Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal SJ, Hurley C, Andersen C, Margossian S, Neelapu SS, Shpall E, Gutierrez C, Tewari P, Shoberu B, Talleur A, McCall D, Nunez C, Cuglievan B, Tambaro FP, Petropoulos D, Abdel-Azim H, Mahadeo KM. A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy. Front Oncol 12:1022901, 2022. e-Pub 2022. PMID: 36353531.
- Ariagno S, Ragoonanan D, Khazal S, Mahadeo KM, Cisneros GS, Zinter MS, Blacken RA, Mohan G, Lehmann LE, Ferdjallah A, Mara KC, Kohorst MA. Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation. Front Oncol 12:1000215, 2022. e-Pub 2023. PMID: 36733348.
- Li W, Ye L, Carrion R, Mohan GS, Nunneley J, Staples H, Ticer A, Patterson JL, Compans RW, Yang C. Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice. J Infect Dis 212 Suppl 2(Suppl 2):S398-403, 2015. e-Pub 2015. PMID: 25877553.
- Mohan GS, Ye L, Li W, Monteiro A, Lin X, Sapkota B, Pollack BP, Compans RW, Yang C. Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity. J Virol 89(2):1205-17, 2015. e-Pub 2014. PMID: 25392212.
- Mohan GS, Li W, Ye L, Compans RW, Yang C. Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog 8(12):e1003065, 2012. e-Pub 2012. PMID: 23271969.
- Zhang H, Garber SJ, Cui Z, Foley JP, Mohan GS, Jobanputra M, Kaplan F, Sweezey NB, Gonzales LW, Savani RC. The angiogenic factor midkine is regulated by dexamethasone and retinoic acid during alveolarization and in alveolar epithelial cells. Respir Res 10(1):77, 2009. e-Pub 2009. PMID: 19698107.
- DeLisser HM, Helmke BP, Cao G, Egan PM, Taichman D, Fehrenbach M, Zaman A, Cui Z, Mohan GS, Baldwin HS, Davies PF, Savani RC. Loss of PECAM-1 function impairs alveolarization. J Biol Chem 281(13):8724-31, 2006. e-Pub 2005. PMID: 16377626.